Evidence map›Paper›PMID 33908345›Full record

ArticleeLife2021

The final step of 40S ribosomal subunit maturation is controlled by a dual key lock.

Laura Plassart, Ramtin Shayan, Christian Montellese, Dana Rinaldi, Natacha Larburu, Carole Pichereaux, Carine Froment, Simon Lebaron, Marie-Françoise O'Donohue, Ulrike Kutay and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Laura Plassart *Molecular, Cellular and Developmental Biology department (MCD), Centre de Biologie Integrative (CBI), University of Toulouse, CNRS, UPS, Toulouse, France.
Ramtin Shayan *Molecular, Cellular and Developmental Biology department (MCD), Centre de Biologie Integrative (CBI), University of Toulouse, CNRS, UPS, Toulouse, France.
Christian MontelleseInstitut für Biochemie, ETH Zürich, Zurich, Switzerland.
Dana RinaldiMolecular, Cellular and Developmental Biology department (MCD), Centre de Biologie Integrative (CBI), University of Toulouse, CNRS, UPS, Toulouse, France.
Natacha LarburuMolecular, Cellular and Developmental Biology department (MCD), Centre de Biologie Integrative (CBI), University of Toulouse, CNRS, UPS, Toulouse, France.
Carole PichereauxInstitut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France.
Carine FromentInstitut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France.
Simon LebaronMolecular, Cellular and Developmental Biology department (MCD), Centre de Biologie Integrative (CBI), University of Toulouse, CNRS, UPS, Toulouse, France.
Marie-Françoise O'DonohueMolecular, Cellular and Developmental Biology department (MCD), Centre de Biologie Integrative (CBI), University of Toulouse, CNRS, UPS, Toulouse, France.
Ulrike KutayInstitut für Biochemie, ETH Zürich, Zurich, Switzerland.ORCID 0000-0002-8257-7465
Julien MarcouxInstitut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France.ORCID 0000-0001-7321-7436
Pierre-Emmanuel Gleizes *Molecular, Cellular and Developmental Biology department (MCD), Centre de Biologie Integrative (CBI), University of Toulouse, CNRS, UPS, Toulouse, France.ORCID 0000-0003-0830-7341
Celia Plisson-Chastang *Molecular, Cellular and Developmental Biology department (MCD), Centre de Biologie Integrative (CBI), University of Toulouse, CNRS, UPS, Toulouse, France.ORCID 0000-0002-8439-8428
Centre National de la Recherche Scientifique · FRETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preventing premature interaction of pre-ribosomes with the translation apparatus is essential for translational accuracy. Hence, the final maturation step releasing functional 40S ribosomal subunits, namely processing of the 18S ribosomal RNA 3' end, is safeguarded by the protein DIM2, which both interacts with the endoribonuclease NOB1 and masks the rRNA cleavage site. To elucidate the control mechanism that unlocks NOB1 activity, we performed cryo-electron microscopy analysis of late human pre-40S particles purified using a catalytically inactive form of the ATPase RIO1. These structures, together with in vivo and in vitro functional analyses, support a model in which ATP-loaded RIO1 cooperates with ribosomal protein RPS26/eS26 to displace DIM2 from the 18S rRNA 3' end, thereby triggering final cleavage by NOB1; release of ADP then leads to RIO1 dissociation from the 40S subunit. This dual key lock mechanism requiring RIO1 and RPS26 guarantees the precise timing of pre-40S particle conversion into translation-competent ribosomal subunits.

Indexed as

Cell Cycle ProteinsHumansNuclear ProteinsProtein Serine-Threonine KinasesRibosomal ProteinsRibosome Subunits, Small, EukaryoticRNA-Binding ProteinsCell Cycle ProteinsNOB1 protein, humanNuclear ProteinsProtein Serine-Threonine KinasesRibosomal ProteinsRIOK1 protein, humanRNA-Binding ProteinsRPS26 protein, humanTXNL4B protein, humanchromosomescryo-EMgene expressionhumanhuman ribosome biogenesismolecular biophysicspre-rRNA processingsmall ribosomal subunitstructural biologystructure-function study

Identifiers

PMID33908345
PMCPMC8112863
OpenAlexW3046742242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.